Advertisement

Starting a minimally invasive inguinal lymphadenectomy program: Initial learning experience and outcomes

Published:November 12, 2022DOI:https://doi.org/10.1016/j.surg.2022.07.052

      Abstract

      Background

      There is promising data on minimally invasive inguinal lymphadenectomy indicating decreased wound complications compared with the standard open approach. We examined our institutional experience with starting a minimally invasive inguinal lymphadenectomy program.

      Methods

      This is a retrospective case series of consecutive patients undergoing videoscopic minimally invasive inguinal lymphadenectomy from August 2017 to March 2022 by a single surgeon. Patients meeting criteria for inguinal lymphadenectomy were considered for minimally invasive inguinal lymphadenectomy unless there was skin involvement by tumor or bulky disease. Data collected included patient characteristics, primary cancer, surgery, and postoperative complications.

      Results

      There were 26 patients included. The mean age was 60.6 ± 16.2 years. Most patients were female (n = 17, 65.4%), and the primary diagnosis was melanoma (n = 21, 19.2%). In 6 cases (23.1%), minimally invasive inguinal lymphadenectomy was combined with deep pelvic node dissection, but most patients did not have a concurrent procedure (n = 15, 57.7%). The median operative time was 119.0 minutes (range, 89.0–160.0), or 130.5 minutes (range, 89.0–345.0) when including concurrent procedures. The mean number of nodes retrieved was 9.8 ± 3.7, with a positive node identified in 19 patients (73.1%) during minimally invasive inguinal lymphadenectomy. There were 12 (46.2%) patients experiencing at least one postoperative complication within 30 days of surgery, the most common being infection (n = 4, 15.4%). One patient required reoperation for infected hematoma washout. Postoperative intervention for seroma was undertaken in 3 patients (11.5%).

      Conclusion

      Minimally invasive inguinal lymphadenectomy is a safe approach to inguinal lymph node dissection, in terms of node retrieval and postoperative complications, and can feasibly be adopted into practice with minimal learning curve.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Balch C.M.
        • Balch G.C.
        • Thompson J.F.
        Surgical management of metastatic melanoma (stage III and IV disease).
        in: Morita S.Y. Balch C.M. Klimberg V.S. Pawlik T.M. Posner M.C. Tanabe K.K. Textbook of Complex General Surgical Oncology. McGraw-Hill Education, New York, NY2018
        • Faries M.B.
        • Thompson J.F.
        • Cochran A.J.
        • et al.
        Completion dissection or observation for sentinel-node metastasis in melanoma.
        N Engl J Med. 2017; 376: 2211-2222
        • Ghaferi A.A.
        • Sabel M.S.
        Chapter 28. Operative management of melanoma.
        in: Minter R.M. Doherty G.M. CURRENT Procedures: Surgery. The McGraw-Hill Companies, New York, NY2010
        • Shaw J.H.
        • Rumball E.M.
        Complications and local recurrence following lymphadenectomy.
        Br J Surg. 1990; 77: 760-764
        • Chang S.B.
        • Askew R.L.
        • Xing Y.
        • et al.
        Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.
        Ann Surg Oncol. 2010; 17: 2764-2772
        • Trias M.
        • Targarona E.M.
        • Piulachs J.
        • et al.
        Extraperitoneal laparoscopically assisted ilioinguinal lymphadenectomy for treatment of malignant melanoma.
        Arch Surg. 1998; 133: 272-275
        • Bishoff J.T.
        • Basler J.W.
        • Teichman J.M.
        • Thompson I.M.
        Endoscopic subcutaneous modified inguinal lymph node dissection (ESMIL) for squamous cell carcinoma of the penis.
        J Urol. 2003; 169: 78
        • Sotelo R.
        • Sánchez-Salas R.
        • Carmona O.
        • et al.
        Endoscopic lymphadenectomy for penile carcinoma.
        J Endourol. 2007; 21: 364-367
        • Tobias-Machado M.
        • Tavares A.
        • Molina W.J.
        • et al.
        Video endoscopic inguinal lymphadenectomy (VEIL): initial case report and comparison with open radical procedure.
        Arch Esp Urol. 2006; 59: 849-852
        • Delman K.A.
        • Kooby D.A.
        • Ogan K.
        • Hsiao W.
        • Master V.
        Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma.
        Ann Surg Oncol. 2010; 17: 731-737
        • Martin B.M.
        • Etra J.W.
        • Russell M.C.
        • et al.
        Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma.
        J Am Coll Surg. 2014; 218: 620-626
        • Postlewait L.M.
        • Farley C.R.
        • Diller M.L.
        • et al.
        A minimally invasive approach for inguinal lymphadenectomy in melanoma and genitourinary malignancy: long-term outcomes in an attempted randomized control trial.
        Ann Surg Oncol. 2017; 24: 3237-3244
        • Jakub J.W.
        • Lowe M.
        • Howard J.H.
        • et al.
        Oncologic outcomes of multi-institutional minimally invasive inguinal lymph node dissection for melanoma compared with open inguinal dissection in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
        Ann Surg Oncol. 2022; 29: 5910-5920
        • Abbott A.M.
        • Grotz T.E.
        • Rueth N.M.
        • Hernandez Irizarry R.C.
        • Tuttle T.M.
        • Jakub J.W.
        Minimally invasive inguinal lymph node dissection (MILND) for melanoma: experience from two academic centers.
        Ann Surg Oncol. 2013; 20: 340-345
        • Sommariva A.
        • Pasquali S.
        • Cona C.
        • et al.
        Videoscopic ilioinguinal lymphadenectomy for groin lymph node metastases from melanoma.
        Br J Surg. 2016; 103: 1026-1032
        • Sommariva A.
        • Cona C.
        • Tonello M.
        • Pilati P.
        • Rossi C.R.
        Oncological outcome of videoscopic groin dissection for lymph node metastasis from melanoma.
        Surg Endosc. 2021; 35: 2576-2582
        • Jakub J.W.
        • Terando A.M.
        • Sarnaik A.
        • et al.
        Training high-volume melanoma surgeons to perform a novel minimally invasive inguinal lymphadenectomy: report of a prospective multi-institutional trial.
        J Am Coll Surg. 2016; 222: 253-260
        • Harris P.A.
        • Taylor R.
        • Minor B.L.
        • et al.
        The REDCap consortium: building an international community of software platform partners.
        J Biomed Inform. 2019; 95: 103208
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009; 42: 377-381
        • Centers for Disease Control and Prevention
        Surgical site infection (SSI) event.
        National Healthcare Safety Network, 2022 (Available from:)
        • Delman K.A.
        • Kooby D.A.
        • Rizzo M.
        • Ogan K.
        • Master V.
        Initial experience with videoscopic inguinal lymphadenectomy.
        Ann Surg Oncol. 2011; 18: 977-982
        • Sabel M.S.
        • Griffith K.A.
        • Arora A.
        • et al.
        Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
        Surgery. 2007; 141: 728-735
        • Hughes T.M.
        • Thomas J.M.
        Combined inguinal and pelvic lymph node dissection for stage III melanoma.
        Br J Surg. 1999; 86: 1493-1498
        • Poos H.P.A.M.
        • Kruijff S.
        • Bastiaannet E.
        • van Ginkel R.J.
        • Hoekstra H.J.
        Therapeutic groin dissection for melanoma: risk factors for short term morbidity.
        Eur J Surg Oncol. 2009; 35: 877-883
        • Mortenson M.M.
        • Xing Y.
        • Weaver S.
        • et al.
        Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).
        World J Surg Oncol. 2008; 6: 1-8
        • Strobbe L.J.
        • Jonk A.
        • Hart A.A.
        • Nieweg O.E.
        • Kroon B.B.
        Positive iliac and obturator nodes in melanoma: survival and prognostic factors.
        Ann Surg Oncol. 1999; 6: 255-262
        • Beitsch P.
        • Balch C.
        Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection.
        Am J Surg. 1992; 164: 462-466
        • de Vries M.
        • Vonkeman W.G.
        • van Ginkel R.J.
        • Hoekstra H.J.
        Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
        Eur J Surg Oncol. 2006; 32: 785-789
        • van Akkooi A.C.J.
        • Bouwhuis M.G.
        • van Geel A.N.
        • et al.
        Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.
        Eur J Surg Oncol. 2007; 33: 102-108
      1. Nabavizadeh R., Petrinec B., Nabavizadeh B., Singh A., Rawal S., Master V. Inguinal lymph node dissection in the era of minimally invasive surgical technology [e-pub ahead of print]. Urol Oncol.

        • Nayak S.P.
        • Pokharkar H.
        • Gurawalia J.
        • Dev K.
        • Chanduri S.
        • Vijayakumar M.
        Efficacy and safety of lateral approach-video endoscopic inguinal lymphadenectomy (L-VEIL) over open inguinal block dissection: a retrospective study.
        Indian J Surg Oncol. 2019; 10: 555-562
        • Le A.
        • Xiong J.
        • Wang Z.
        • Dai X.Y.
        • et al.
        Endoscopy-assisted inguinal lymphadenectomy in vulvar cancer.
        Arch Gynecol Obstet. 2018; 297: 1277-1283
        • Wang S.
        • Du P.
        • Tang X.
        • An C.
        • Zhang N.
        • Yang Y.
        Comparison of efficiency of video endoscopy and open inguinal lymph node dissection.
        Anticancer Res. 2017; 37: 4623-4628
        • Wang H.
        • Li L.
        • Yao D.
        • Li F.
        • Zhang J.
        • Yang Z.
        Preliminary experience of performing a video endoscopic inguinal lymphadenectomy using a hypogastric subcutaneous approach in patients with vulvar cancer.
        Oncol Lett. 2015; 9: 752-756
        • Schwentner C.
        • Todenhöfer T.
        • Seibold J.
        • et al.
        Endoscopic inguinofemoral lymphadenectomy—Extended follow-up.
        J Endourol. 2012; 27: 497-503
        • Romanelli P.
        • Nishimoto R.
        • Suarez R.
        • et al.
        Video endoscopic inguinal lymphadenectomy: surgical and oncological results.
        Actas Urológicas Españolas (English Edition). 2013; 37: 305-310
        • Cemal Y.
        • Kumar V.
        • Moncrieff M.
        Introducing minimally invasive inguinal lymph node dissection in a UK tertiary skin cancer service: initial experience & outcomes.
        J Plast Reconstr Aesthet Surg. 2022; 75: 737-742
        • Culver D.H.
        • Horan T.C.
        • Gaynes R.P.
        • et al.
        Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System.
        Am J Med. 1991; 91: 152S-157S
        • Haley R.W.
        • Culver D.H.
        • Morgan W.M.
        • White J.W.
        • Emori T.G.
        • Hooton T.M.
        Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination.
        Am J Epidemiol. 1985; 121: 206-215
        • Jakub J.W.
        • Terando A.M.
        • Sarnaik A.
        • et al.
        Safety and feasibility of minimally invasive inguinal lymph node dissection in patients with melanoma (SAFE-MILND): report of a prospective multi-institutional trial.
        Ann Surg. 2017; 265: 192-196
        • Farge D.
        • Frere C.
        • Connors J.M.
        • et al.
        2019 International Clinical Practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
        Lancet Oncol. 2019; 20: e566-e581
        • Key N.S.
        • Khorana A.A.
        • Kuderer N.M.
        • et al.
        Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update.
        J Clin Oncol. 2020; 38: 496-520
        • Felder S.
        • Rasmussen M.S.
        • King R.
        • et al.
        Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
        Cochrane Database Syst Rev. 2018; (11CD004318)
        • Fagarasanu A.
        • Alotaibi G.S.
        • Hrimiuc R.
        • Lee A.Y.Y.
        • Wu C.
        Role of extended thromboprophylaxis after abdominal and pelvic surgery in cancer patients: a systematic review and meta-analysis.
        Ann Surg Oncol. 2016; 23: 1422-1430
        • Alshehri N.
        • Cote D.J.
        • Hulou M.M.
        • et al.
        Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis.
        J Neurooncol. 2016; 130: 561-570
        • Arbeit J.M.
        • Lowry S.F.
        • Line B.R.
        • Jones D.C.
        • Brennan M.F.
        Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma.
        Ann Surg. 1981; 194: 648
        • Kumar V.
        • Sethia K.K.
        Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period.
        BJU Int. 2017; 119: 530-534
        • Contreras N.
        • Jakub J.W.
        The Achilles heel of minimally invasive inguinal lymph node dissection: seroma formation.
        Am J Surg. 2020; 219: 696-700
        • Delman K.A.
        Minimally invasive inguinal lymphadenectomy.
        J Surg Oncol. 2020; 122: 96-98